Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa/Benserazide Dispersible for Delayed ON in Parkinson's Disease
NCT02769793Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa, benserazide in Parkinson's disease (PD), sponsored by Seoul National University Hospital. Started Jun 2015; status: completed.
02
Drugs
levodopabenserazide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02769793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769793.